MENU
ENTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Enanta Pharmaceuticals (ENTA) Ownership - Who owns Enanta Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
129.29M
P/E Ratio
N/A
Total Cash
248.19M
Projected Growth
N/A
Total Debt
55.47M
Revenue
67.64M
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
11.71
Total Debt/Equity
N/A
Revenue/Share
3.20 USD as % of share price
Fundamentals
ENTA
Capitalization
129M
P/E Ratio
N/A
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash
248M
Total Cash/Share
11.71
Total Debt
55.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.20%
Revenue
67.6M
ROE
N/A
Book Value
129M
P/B Ratio
1.00
Cash Flow
N/A
Earnings
-5.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
212K
Current Ratio
5.21
Current Revenue Per Employee
111503.82
Dividends Per Share - Security
N/A
EBITDA
-104.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.67
Shares Held By Institutions
269M
Shares Outstanding - Current
21.2M
Total Liabilities
248M
Total Volume MTD
N/A
Value
-1
Gain YTD
-35.175
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs and other pharmaceuticals products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com